… Induced pluripotent stem cells (iPSCs) can be generated from specific patients with
known genotypes and observable phenotypes, and they are therefore ideally suited to …

… stem cells from patient's own skin and their subsequent differentiation into cell types lost by
neurodegenerative diseases … -made patient stem cells are used for cellular transplantation in …

… In the early experience, patients with chronic progressive disease did not respond; this has
shifted the focus to patients with early disease, likely to have a major inflammatory component…

… This paper summarizes a survey of 24 sites performing autologous hematopoietic stem
cell transplants for autoimmune diseases. The data were collected via retrospective survey …

… By using reprogrammed cells from patients disease models 'in a dish' are being developed,
allowing experiments that, until recently, would have been inconceivable. The concept of …

… induced pluripotent stem (iPS) cells from patients with a variety of genetic diseases with either
… Here, we report the derivation of human iPS cell lines from patients with a range of human …

… tissues, can treat mouse disease models and human patients in which epithelial and neural
… stem cells in the clinic as a means for replacing cells that are damaged by disease or injury. …

… the patient suffering from severe injuries or chronic disease. The spectacular progress in
the field of stem cell research has laid the foundation for cell based therapies of disease which …

… replacement therapy is emerging as an innovative approach for the treatment of degenerative
cardiac diseases, and pluripotent stem cells appear to be an ideal source of cells in this …

… stem cells and the potential therapies based on these cells. The genesis of stem cells is followed
by laboratory steps of controlled stem … future life-threatening diseases of a given patient. …